Business Description
Cytophage Technologies Ltd
NAICS : 541713
SIC : 3741
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 1.48 | |||||
Equity-to-Asset | 0.68 | |||||
Debt-to-Equity | 0.38 | |||||
Debt-to-EBITDA | -0.57 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC |
Growth Rank
Name | Current | Vs Industry | Vs History |
---|
Momentum Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 58.33 | |||||
9-Day RSI | 52.9 | |||||
14-Day RSI | 51.73 | |||||
6-1 Month Momentum % | -16.88 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 4.24 | |||||
Quick Ratio | 4.24 | |||||
Cash Ratio | 3.48 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Shareholder Yield % | -21.94 |
Profitability Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
ROE % | -71.65 | |||||
ROA % | -55.62 | |||||
ROIC % | -28.75 | |||||
ROC (Joel Greenblatt) % | -137.59 | |||||
ROCE % | -62.41 | |||||
Years of Profitability over Past 10-Year | 1 |
GF Value Rank
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PB Ratio | 3.96 | |||||
Price-to-Tangible-Book | 3.81 | |||||
EV-to-EBIT | -4.7 | |||||
EV-to-EBITDA | -5.59 | |||||
EV-to-FCF | -4.89 | |||||
Price-to-Net-Current-Asset-Value | 15.25 | |||||
Price-to-Net-Cash | 30.5 | |||||
Earnings Yield (Greenblatt) % | -21.28 | |||||
FCF Yield % | -19.15 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return %
Total Annual Return %
Cytophage Technologies Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil C$) | |||
EPS (TTM) (C$) | -0.027 | ||
Beta | 0 | ||
Volatility % | 0 | ||
14-Day RSI | 51.73 | ||
14-Day ATR (C$) | 0.017649 | ||
20-Day SMA (C$) | 0.30525 | ||
12-1 Month Momentum % | 0 | ||
52-Week Range (C$) | 0.22 - 0.76 | ||
Shares Outstanding (Mil) | 53.94 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 9999 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
Cytophage Technologies Ltd Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
Cytophage Technologies Ltd Stock Events
Event | Date | Price(C$) | ||
---|---|---|---|---|
No Event Data |
Cytophage Technologies Ltd Frequently Asked Questions
What is Cytophage Technologies Ltd(TSXV:CYTO)'s stock price today?
When is next earnings date of Cytophage Technologies Ltd(TSXV:CYTO)?
Does Cytophage Technologies Ltd(TSXV:CYTO) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |